These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7044241)

  • 21. Myocardial infarction size: measurement and modification.
    Cairns JA
    Can Med Assoc J; 1977 Aug; 117(3):255-62. PubMed ID: 69481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Inderal in the acute and post-myocardial infarct periods].
    Popov VG; Martynov IV; Alushkov MV; Voronin VA
    Ter Arkh; 1986; 58(6):53-8. PubMed ID: 3764715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined receptor intervention and myocardial infarction.
    Chamberlain DA; Vincent R
    Drugs; 1984; 28 Suppl 2():88-108. PubMed ID: 6151893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The reduction of infarct size--forty years of research.
    Ferreira R
    Rev Port Cardiol; 2010 Jun; 29(6):1037-53. PubMed ID: 20964114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of cariporide (HOE642) on myocardial infarct size and ventricular arrhythmias in a rat ischemia/reperfusion model: comparison with other drugs.
    Wajima T; Beguier B; Yaguchi M
    Pharmacology; 2004 Feb; 70(2):68-73. PubMed ID: 14685009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modification of myocardial infarct volume. An experimental study in the dog.
    Pierce WS; Carter DR; McGavran MH; Waldhausen JA
    Arch Surg; 1973 Nov; 107(5):682-7. PubMed ID: 4126701
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial.
    Ibanez B; Macaya C; Sánchez-Brunete V; Pizarro G; Fernández-Friera L; Mateos A; Fernández-Ortiz A; García-Ruiz JM; García-Álvarez A; Iñiguez A; Jiménez-Borreguero J; López-Romero P; Fernández-Jiménez R; Goicolea J; Ruiz-Mateos B; Bastante T; Arias M; Iglesias-Vázquez JA; Rodriguez MD; Escalera N; Acebal C; Cabrera JA; Valenciano J; Pérez de Prado A; Fernández-Campos MJ; Casado I; García-Rubira JC; García-Prieto J; Sanz-Rosa D; Cuellas C; Hernández-Antolín R; Albarrán A; Fernández-Vázquez F; de la Torre-Hernández JM; Pocock S; Sanz G; Fuster V
    Circulation; 2013 Oct; 128(14):1495-503. PubMed ID: 24002794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Late potentials, myocardial kinetics and ventricular vulnerability as markers of sudden death after myocardial infarct].
    D'Aulerio M; Gronda M; Prando MD; Occhetta E; Makmur J; Rossi L; Rossi P
    G Ital Cardiol; 1986 Feb; 16(2):114-26. PubMed ID: 3721103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of the beta-blocker propranolol (obzidan) on the content of macroergic phosphates and the development of the size of necrotic areas in the myocardium in experimental acute coronary occlusion].
    Irgashev ShB; Mavridi DI; Iuldashev NM
    Kardiologiia; 1988 Aug; 28(8):86-90. PubMed ID: 3199662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Identification of patients at risk of malignant arrhythmia in the 1st year after myocardial infarction].
    Araya-Gómez V; González-Hermosillo JA; Casanova Garcés JM; Colín L; Kershenovich S; Iturralde P
    Arch Inst Cardiol Mex; 1994; 64(2):145-59. PubMed ID: 8074586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta-Blocker Heart Attack Trial: impact of propranolol therapy on ventricular arrhythmias.
    Morganroth J; Lichstein E; Byington R
    Prev Med; 1985 May; 14(3):346-57. PubMed ID: 3903736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delayed protection against ischaemia-induced ventricular arrhythmias and infarct size limitation by the prior administration of Escherichia coli endotoxin.
    Song W; Furman BL; Parratt JR
    Br J Pharmacol; 1996 Aug; 118(8):2157-63. PubMed ID: 8864556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of SQ 26,533 on reperfusion arrhythmias, ST-segment elevation and on infarct size in anesthetized dogs.
    Saini RK; Fulmor IE; Parham CS; Antonaccio MJ
    J Pharmacol Exp Ther; 1986 Apr; 237(1):1-8. PubMed ID: 3958960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrophysiologic actions of UM-272 (Pranolium) on reentrant ventricular arrhythmias in postinfarction canine myocardium.
    Gibson JK; Lucchesi BR
    J Pharmacol Exp Ther; 1980 Aug; 214(2):347-53. PubMed ID: 7391982
    [No Abstract]   [Full Text] [Related]  

  • 35. [The effect of a limited area of infarction on the course of ischemic heart disease in patients with a history of myocardial infarct].
    Sledzevskaia IK; Il'iash MG; Sirenko IuN; Malinovskaia IE; Mironova OV
    Vrach Delo; 1991 Jan; (1):47-50. PubMed ID: 2011892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of propranolol on ischemic myocardial damage and left ventricular hypertrophy following permanent coronary artery occlusion or occlusion followed by reperfusion.
    Smith EF; Egan JW; Griswold DE
    Pharmacology; 1989; 38(5):298-309. PubMed ID: 2527373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of captopril and losartan on myocardial ischemia-reperfusion induced arrhythmias and necrosis in rats.
    Ozer MK; Sahna E; Birincioglu M; Acet A
    Pharmacol Res; 2002 Apr; 45(4):257-63. PubMed ID: 12030787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ventricular arrhythmias and sudden cardiac death in acute myocardial infarct in the era of thrombolytics].
    Jurkovicová O; Spitzerová H; Cagán S
    Bratisl Lek Listy; 1997; 98(7-8):379-89. PubMed ID: 9471331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Obzidan inhibition of lipid free-radical peroxidation in coronary-occluding myocardial infarct].
    Luk'ianova LO; Kudrin AN; Kogan AKh
    Farmakol Toksikol; 1983; 46(1):45-8. PubMed ID: 6825817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of KR-32570, a new sodium hydrogen exchanger inhibitor, on myocardial infarction and arrhythmias induced by ischemia and reperfusion.
    Lee BH; Yi KY; Lee S; Lee S; Yoo SE
    Eur J Pharmacol; 2005 Oct; 523(1-3):101-8. PubMed ID: 16226744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.